Trials / Sponsors / ABL Bio, Inc.
ABL Bio, Inc.
Industry · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors Solid Tumors | Phase 1 / Phase 2 | 2025-08-06 |
| Recruiting | A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-11-07 |
| Completed | This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Par Healthy | Phase 1 | 2022-12-31 |
| Completed | Study to Evaluate the Safety and Tolerability of ABL501, and to Determine the Maximum Tolerated Dose (MTD) and Advanced Solid Tumor | Phase 1 | 2021-10-06 |
| Recruiting | This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose Advanced Solid Tumor | Phase 1 | 2021-04-01 |
| Completed | This is a Study to Evaluate the Safety and Tolerability of the Study Drug ABL001, and to Determine the Maximum Advanced Solid Tumors | Phase 1 | 2017-09-18 |